Glucagon-like peptide1 receptor agonists

Abstract

In an embodiment, the present invention provides a compound of the formula:or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.

1 - 20 . (canceled) 
     
     
         21 . A compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
       
       and a pharmaceutically acceptable salt thereof. 
     
     
         22 . The compound according to  claim 21 , wherein the compound is selected from the group consisting: 
       
         
           
           
               
               
           
         
       
       and a pharmaceutically acceptable salt thereof. 
     
     
         23 . The compound according to  claim 21 , wherein the compound is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         24 . The compound according to  claim 21 , wherein the compound is: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         25 . A pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt thereof, according to  claim 21  and at least one pharmaceutically acceptable carrier, diluent, or excipient. 
     
     
         26 . A method of treating type II diabetes mellitus in a mammal comprising administering to the mammal an effective amount of a compound according to  claim 21 , or a pharmaceutically acceptable salt thereof. 
     
     
         27 . The method according to  claim 26 , wherein the compound is administered orally. 
     
     
         28 . A method of lowering blood glucose levels in a mammal comprising administering an effective amount of a compound according to  claim 21 , or a pharmaceutically acceptable salt thereof. 
     
     
         29 . The method according to  claim 28 , wherein the compound is administered orally. 
     
     
         30 . A method of treating hyperglycemia in a mammal comprising administering to the mammal an effective amount of a compound according to  claim 21 , or a pharmaceutically acceptable salt thereof. 
     
     
         31 . The method according to  claim 30 , wherein the compound is administered orally.